Osteogenesis imperfecta type 14 is a rare genetic condition that mainly affects bone strength, so bones can break easily and growth may be affected. It is usually present from birth or early childhood, but signs can vary and not everyone will have the same experience. Many living with osteogenesis imperfecta type 14 also have short stature, bone deformities, and sometimes a blue or gray tint to the whites of the eyes, and early signs of osteogenesis imperfecta type 14 may first appear after repeated fractures. The condition is lifelong, and severe cases can lead to serious breathing problems or other complications, especially in infancy, while milder cases are often compatible with a long life. Treatment focuses on ongoing care such as fracture management, physical therapy, mobility support, and sometimes medicines that help strengthen bone.
How many people live with Osteogenesis imperfecta type 14?
For the broader brittle bone condition called osteogenesis imperfecta, a worldwide rate of 6 to 7 in 100,000 works out to about 490,000 to 570,000 people globally (MedlinePlus Genetics, 2024), and about 25,000 to 50,000 people live with it in the United States (Osteogenesis Imperfecta Foundation, 2024). Osteogenesis imperfecta type 14 is much rarer: Orphanet lists it as fewer than 1 in 1,000,000, which suggests fewer than about 8,000 people worldwide and fewer than about 350 in the U.S.; compared with all osteogenesis imperfecta, that is less than about 1% to 2% of cases, so this is an estimate rather than a direct count (Orphanet, 2024).
Overview
Osteogenesis imperfecta type 14Symptoms
Osteogenesis imperfecta type 14 mainly causes fragile bones that break easily, often starting before birth or in early childhood. Many living with osteogenesis imperfecta type 14 also have short stature and may develop bone deformities as they grow.
Outlook and prognosis
With osteogenesis imperfecta type 14, outlook varies, but many people have repeated fractures from infancy, short stature, and bone changes that need ongoing specialist care. Early treatment, physical therapy, and safe mobility support can improve comfort, strength, and day-to-day independence.
Causes and risk factors
Osteogenesis imperfecta type 14 is caused by changes in TMEM38B, usually inherited from both parents, though new changes can happen. Family history raises risk. Nutrition, falls, and low activity can worsen bone fragility.
Genetic influences
Genetics are central to osteogenesis imperfecta type 14. It is caused by changes in the TMEM38B gene, usually inherited in an autosomal recessive pattern, meaning both copies are affected. Genetic testing can confirm the diagnosis and help with family planning.
Diagnosis
Doctors suspect Osteogenesis imperfecta type 14 from clinical features such as frequent fractures and imaging findings. The diagnosis of Osteogenesis imperfecta type 14 is confirmed with genetic tests. Family history may also help.
Treatment and drugs
Treatment for Osteogenesis imperfecta type 14 focuses on preventing fractures and helping movement. Care often includes physical therapy, orthopedic support such as braces or surgery, and medicines that may help strengthen bone. Genetic counseling can also help families plan care.
Symptoms
Osteogenesis imperfecta type 14 often affects day-to-day life through fragile bones, repeated fractures, and slower growth. The early features of Osteogenesis imperfecta type 14 may include broken bones after minor injuries, low bone strength, and changes in the shape of the arms, legs, or spine. Symptoms vary from person to person and can change over time. Some children have a milder pattern, while others need regular support with pain, movement, and bone care.
Bones can break after a minor bump, a simple fall, or sometimes with no clear injury at all. In some children, fractures start before birth or in the newborn period, while in others they become clear later in infancy or childhood.
In Osteogenesis imperfecta type 14, bones are often less dense and less strong than usual. This can make cracks, breaks, and compression of the bones more likely even during everyday activity.
Many children grow more slowly and are shorter than expected for their family. Repeated fractures and weak bones can also make standing, walking, and active play harder over time.
Arm or leg bones may bow, curve, or heal in an unusual position after fractures. This can affect balance and walking and may make daily movement more tiring.
How people usually first notice Osteogenesis imperfecta type 14?
Osteogenesis imperfecta type 14 is often first noticed very early, sometimes before birth on ultrasound if bones look unusually short, bowed, or fragile, and sometimes right after delivery when a baby has fractures with little or no obvious injury. In other children, the first signs of osteogenesis imperfecta type 14 appear in infancy, when families or doctors notice repeated broken bones, slow growth, or limbs that curve more than expected. Because these early findings can overlap with other bone conditions, doctors usually confirm how osteogenesis imperfecta type 14 is first noticed with imaging and genetic testing, which can give families clearer answers and guide care.
Types of Osteogenesis imperfecta type 14
No distinct types of Osteogenesis imperfecta type 14 are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medical treatment can meaningfully delay the start of symptoms in osteogenesis imperfecta type 14, because it is an inherited brittle bone condition that usually begins before birth or in early childhood. Healthy habits such as safe movement with physical therapy guidance, food that supports bone health, enough sleep, and not smoking may help overall health and may lower the chance of some injuries or later complications, but they do not prevent the condition itself. Early care with a bone specialist and regular follow-up can help treat fractures, pain, and growth problems sooner, and while this cannot stop symptoms from starting, it can still help many living with this condition stay as safe and active as possible.
What genetics can tell you about symptoms
For people with osteogenesis imperfecta type 14, genetics can help explain why symptoms can look different from one person to another, even within the same family. Changes in the gene linked to this type affect how bone tissue forms and stays strong, so genetic testing may give clues about whether fragile bones, frequent fractures, poor growth, or bone shape changes are likely to be milder or more severe and whether problems begin very early in life. Still, genes do not predict everything, and many living with this condition have a range of symptoms that only becomes clearer over time.
Causes and risk factors
The main cause of osteogenesis imperfecta type 14 is a change in the TMEM38B gene, which helps bones become strong. It is usually inherited when both parents pass on a nonworking copy, so family history and parents who are blood relatives can raise the chance in a child. The gene change is the underlying cause, but the severity of osteogenesis imperfecta type 14 can differ from one person to another. Risk can vary widely from person to person. Low vitamin D, poor nutrition, little safe movement, and frequent falls can worsen bone weakness and make fractures more likely.
What are the most common causes or risk factors?
Osteogenesis imperfecta type 14 is almost always caused by inherited changes in a gene called TMEM38B, so the main risk factor is having both parents carry a changed copy and each pass one on to their child. This type is usually passed down in a recessive way, which means a child typically needs two changed copies to have the condition, and the chance can be higher with a family history or when the parents are closely related by blood. There are no known lifestyle, diet, or pregnancy-related causes.
Environmental and biological risk factors
When people look into risk factors for osteogenesis imperfecta type 14, most of what doctors know points to body-based factors present very early in development. Doctors often group risks into internal (biological) and external (environmental). For this type, clear environmental triggers have not been firmly established.
Osteogenesis imperfecta type 14 begins with a body-based change that is already present from the earliest stages of development. It is not known to start because of routine exercise, normal day-to-day stress, or ordinary activities during pregnancy.
The condition is more likely when both parents carry the same hidden underlying change, even if neither has symptoms. This can make osteogenesis imperfecta type 14 appear in a family with no earlier diagnosis.
The chance is higher when the parents are blood relatives, such as cousins, because they are more likely to share the same underlying change. This is a recognized risk pattern for several rare conditions, including osteogenesis imperfecta type 14.
No common medicine, food, infection, or pollution exposure has been clearly shown to cause osteogenesis imperfecta type 14 on its own. At this time, there are no well-established environmental risk factors for this specific type.
Genetic risk factors
Osteogenesis imperfecta type 14 usually comes to light in families with no warning signs, because it most often appears only when a child inherits two nonworking copies of a gene called TMEM38B. Some risk factors are inherited through our genes. For families wondering about the genetic causes of osteogenesis imperfecta type 14, the key question is whether both biological parents carry the same gene change. Most carriers stay healthy and do not know they carry it.
TMEM38B gene: Osteogenesis imperfecta type 14 is caused by harmful changes in both copies of the TMEM38B gene. This gene helps bone-forming cells handle signals needed to build and maintain strong bone.
Recessive pattern: This condition follows a recessive inheritance pattern, meaning a child must receive one changed TMEM38B copy from each biological parent. People with only one changed copy are usually healthy carriers. Boys and girls can be affected equally.
Carrier parents: If both biological parents are carriers, each pregnancy has a 25% chance of osteogenesis imperfecta type 14, a 50% chance of having a carrier child, and a 25% chance of having a child who did not inherit the gene change. These odds are the same in every pregnancy.
Family history: A known TMEM38B change in the family raises the chance that relatives may also be carriers. This matters most when there is already a child, brother, or sister with osteogenesis imperfecta type 14.
Related parents: When biological parents are related by blood, they are more likely to carry the same rare TMEM38B change. That makes recessive conditions like osteogenesis imperfecta type 14 more likely.
Lifestyle risk factors
Osteogenesis imperfecta type 14 is a genetic bone-fragility disorder, so lifestyle habits do not cause it. However, how lifestyle affects osteogenesis imperfecta type 14 can be important for fracture risk, mobility, pain, muscle strength, and day-to-day function. The most helpful habits are those that protect fragile bones while supporting safe movement, nutrition, and recovery.
Regular, low-impact exercise can improve muscle strength, balance, and joint support, which may lower fall and fracture risk in osteogenesis imperfecta type 14. Activities such as supervised physiotherapy, swimming, or water-based exercise are often better tolerated than high-impact sports.
Contact sports, jumping, and other high-impact activities can place sudden force on fragile bones and increase the chance of fractures. Choosing safer movement patterns and adapted recreation can help preserve mobility without adding unnecessary injury risk.
Inadequate calcium intake can make it harder to support bone mineralization and overall skeletal health in someone who already has brittle bones. Meeting calcium needs through food, and supplements if prescribed, may help support bone strength as part of ongoing care.
Low vitamin D can worsen poor bone mineralization and may increase weakness or fracture susceptibility in osteogenesis imperfecta type 14. Good vitamin D intake, when guided by a clinician, supports calcium absorption and bone health.
Risk prevention
Osteogenesis imperfecta type 14 is a rare inherited bone condition, so there is usually no way to prevent the condition itself if the gene change is present. Prevention is mainly about lowering the chance of fractures, protecting breathing and mobility, and catching problems early so daily life is safer and more manageable. For many, this can mean planning ahead for falls, school or work activities, and times of rapid growth when bones may be under more stress. Prevention works best when combined with regular check-ups.
Regular care with a team familiar with osteogenesis imperfecta type 14 can help spot bone, spine, hearing, dental, and growth problems early. This can lower the risk of complications and guide safer day-to-day activities.
Some people with osteogenesis imperfecta type 14 may be offered medicines that help strengthen bone and reduce fracture risk. These treatments work best when they are paired with monitoring, nutrition, and physical therapy.
Guided exercise and physical therapy can build muscle, improve balance, and support joints without putting too much stress on fragile bones. This is often one of the most helpful ways to prevent falls and repeat fractures in osteogenesis imperfecta type 14.
Simple home and school changes, such as clear walkways, supportive footwear, and well-fitted mobility aids, can reduce accidents. If early symptoms of osteogenesis imperfecta type 14 include frequent fractures with minor bumps, extra safety planning becomes even more important.
Can you prevent Osteogenesis imperfecta type 14?
No, osteogenesis imperfecta type 14 usually cannot be prevented, because it is caused by an inherited gene change that affects how bones grow and stay strong. There are no proven lifestyle changes that can stop it from happening. If it runs in your family, talking with a genetics specialist before pregnancy may help you understand the chances for a future child.
Transmission
Osteogenesis imperfecta type 14 is not infectious, so it cannot be caught from someone else through touch, coughing, blood, sex, food, or everyday contact. Instead, the genetic transmission of Osteogenesis imperfecta type 14 usually happens when a child inherits two nonworking copies of the related gene, one from each parent.
This means many living with Osteogenesis imperfecta type 14 are born to parents who each carry one changed copy but do not have the condition themselves. In most families, if both parents are carriers, each pregnancy has a 25% chance of Osteogenesis imperfecta type 14, a 50% chance the child will be an unaffected carrier, and a 25% chance the child will inherit neither changed copy.
When to test your genes
Consider genetic testing if a baby or child has repeated fractures with little trauma, unusually fragile bones, short stature, or a family history of osteogenesis imperfecta. A confirmed result can clarify the subtype, guide bone monitoring and treatment, and inform reproductive counseling for relatives.
Diagnosis
Osteogenesis imperfecta type 14 is often suspected when a baby, child, or sometimes an adult has repeated fractures, low bone density, or bones that seem unusually fragile after minor bumps or falls. Doctors also look at growth, bone shape, and whether there is a family history of brittle bones, although some families have no clear history at first. Getting a diagnosis is often a turning point toward answers and support, and the genetic diagnosis of Osteogenesis imperfecta type 14 is usually confirmed with specific DNA testing.
Doctors begin by looking for patterns such as frequent fractures, short stature, bone deformities, and delayed motor milestones. The exact signs can vary, so some people with Osteogenesis imperfecta type 14 are recognized early while others are diagnosed later.
A detailed health and family history can help show whether fractures happened after very minor injuries and whether relatives had similar problems. This also helps doctors consider other causes of fragile bones before settling on the diagnosis of Osteogenesis imperfecta type 14.
Imaging findings often show fractures at different stages of healing, thin bones, or changes in bone shape. X-rays can also help rule out other bone disorders that may look similar at first.
A bone density scan may show lower-than-expected bone strength for age. This test supports the overall picture, but it does not by itself prove Osteogenesis imperfecta type 14.
How is Osteogenesis imperfecta type 14 diagnosed?
Doctors usually suspect osteogenesis imperfecta type 14 when a baby or child has repeated broken bones after little or no injury, along with signs such as poor growth, curved bones, or bones that look unusually fragile on X-rays. They also look at the medical and family history and may do scans to check bone strength and shape. Because this type can look very similar to other brittle bone conditions, the diagnosis is usually confirmed with a genetic test that looks for a change in the TMEM38B gene, which is the gene linked to type 14.
Stages of Osteogenesis imperfecta type 14
Osteogenesis imperfecta type 14 does not have defined progression stages. This is because it is a genetic bone condition that can look different from one person to another, rather than moving through a set step-by-step pattern over time. Doctors usually start with a conversation about fractures, bone pain, growth, and family history, along with an exam and imaging such as X-rays to look for signs of fragile bones. In many living with Osteogenesis imperfecta type 14, monitoring focuses on fracture pattern, mobility, growth, and other early symptoms of Osteogenesis imperfecta type 14, sometimes with genetic testing to confirm the diagnosis.
Outlook and prognosis
Outlook in osteogenesis imperfecta type 14 is variable, but many affected children have significant bone fragility with recurrent fractures, growth impairment, and progressive skeletal deformity that can continue throughout life. Prognosis depends largely on severity at presentation, the degree of chest wall and spine involvement, and how well fractures, mobility, and respiratory issues are managed. In milder cases, people may survive into adulthood with supportive care, physical rehabilitation, orthopedic treatment, and often bisphosphonate therapy to improve bone strength and reduce fracture burden. In more severe cases, especially when there are multiple fractures before birth, marked short stature, or restrictive lung disease from rib and spinal deformities, disability can be substantial and life expectancy may be reduced. Mortality is mainly related to complications such as respiratory insufficiency, severe skeletal complications, and less commonly trauma or postoperative complications, rather than the bone disorder alone. Because osteogenesis imperfecta type 14 is rare, long-term survival data are limited, but early multidisciplinary care generally improves function, comfort, and overall outcome.
Long-term effects
Many people living with osteogenesis imperfecta type 14 have long-term effects that center on fragile bones, growth differences, and how the chest, spine, teeth, and hearing develop over time. Long-term effects vary widely, and the outlook often depends on how severe the bone fragility is in childhood and whether fractures, spine curvature, or breathing problems build up over the years. For many, this can mean periods of relative stability mixed with times when new fractures or skeletal changes affect mobility and daily life.
Bones can break easily, sometimes after minor bumps or falls, and repeated fractures may continue across childhood and adult life. Early symptoms of osteogenesis imperfecta type 14 often include broken bones in infancy or early childhood, and later fractures can add to long-term disability.
Many people with osteogenesis imperfecta type 14 grow more slowly than expected and remain shorter than average as adults. This often reflects both the underlying bone condition and the effects of repeated fractures or bone deformities during growth.
Long bones in the arms or legs may gradually bow or heal in an altered shape after repeated breaks. Over time, this can affect balance, walking, standing, and how much physical support a person needs.
Curving of the spine, including scoliosis or kyphosis, can become more noticeable with age in some people with osteogenesis imperfecta type 14. If the curve is significant, it may affect posture, sitting comfort, and sometimes breathing.
How is it to live with Osteogenesis imperfecta type 14?
Living with osteogenesis imperfecta type 14 often means planning around bone fragility, because even minor falls, rough play, or everyday bumps can lead to fractures, and many living with this condition also cope with short stature, bone pain, or limited mobility. Daily life may involve physical therapy, orthopedic care, mobility aids, and extra caution at home, school, or work, but the impact varies widely, and some people remain quite active with the right supports in place. For families, friends, and caregivers, this can mean helping with safe movement, transportation, and recovery after injuries while also learning an important balance: protecting someone from avoidable harm without limiting independence more than necessary.
Treatment and drugs
People living with osteogenesis imperfecta type 14 are usually treated with a plan aimed at lowering fracture risk, supporting growth and movement, and making everyday activities safer and less painful. Treatment plans often combine several approaches: physical therapy to build strength and protect joints, mobility aids or braces when needed, and careful orthopedic care for broken bones or curved bones, sometimes including surgery to place rods inside long bones. Many with osteogenesis imperfecta type 14 are also offered bone-strengthening medicines, often bisphosphonates, although the benefit can vary from one child or adult to another. Because this condition can affect more than bones, care may also include checks for teeth, hearing, breathing, and spine problems, especially if early symptoms of osteogenesis imperfecta type 14 are affecting daily life. Supportive care can make a real difference in how you feel day to day, and regular follow-up with a specialist team helps adjust treatment as needs change over time.
Can you cure Osteogenesis imperfecta type 14?
No, osteogenesis imperfecta type 14 cannot currently be cured. It is a lifelong genetic condition, but treatment can still make a real difference by helping reduce broken bones, support growth and movement, manage pain, and treat problems like bone deformities or weak muscles. Many people living with this condition are helped by a mix of regular follow-up care, physical therapy, mobility aids, and sometimes medicines or surgery.
Non-drug treatment
Daily life with Osteogenesis imperfecta type 14 often centers on preventing fractures, protecting movement, and making everyday tasks safer and easier. Managing this condition often means using supportive care from a team that may include physical and occupational therapists, orthopedic specialists, dentists, hearing specialists, and rehabilitation professionals. The best plan depends on age, fracture history, bone shape, muscle strength, and how much pain or fatigue affects day-to-day life. For many families, physical therapy for Osteogenesis imperfecta type 14 becomes an important part of care early on.
Physical therapy helps build strength, improve balance, and support safer movement without putting too much stress on fragile bones. For many, this can mean practicing transfers, walking, and gentle exercises so everyday activities feel more manageable.
Occupational therapy focuses on dressing, bathing, writing, school tasks, and other daily activities that may become harder after fractures or with short stature. Some may find that small changes in technique or equipment make home, school, and work much easier.
Low-impact activity such as water exercise, guided strengthening, and flexibility work can help muscles support the bones and joints. Not every approach works the same way, so exercise plans should be tailored to avoid high-impact sports or twisting movements that raise fracture risk.
Braces, splints, and shoe inserts can improve joint alignment, add support, and sometimes reduce pain during walking or standing. These devices need regular review, especially in growing children, because a poor fit can limit movement instead of helping it.
Your genes may have an impact on how drugs work for you
For people living with osteogenesis imperfecta type 14, medicines used to help with bone strength or pain do not work exactly the same for everyone, in part because the genetic change behind the condition can affect how fragile the bones are and how the body’s bone-making cells respond. This can mean one person has fewer fractures or less bone pain with treatment, while another still needs closer follow-up, dose changes, or a different care plan. At this time, doctors do not usually use gene results alone to pick these medicines for osteogenesis imperfecta type 14, but genetics can still help explain why treatment response may vary from person to person.
Pharmacological treatments
People living with osteogenesis imperfecta type 14 often need medicines to help lower fracture risk, reduce bone pain, and support day-to-day movement. Because this type is rare, drug treatment usually follows the same approach used for other forms of osteogenesis imperfecta, with care tailored to age, fracture history, and bone density. The main medicines are bisphosphonates, while pain relievers may help during fractures or after procedures. Not everyone responds to the same medication in the same way.
Pamidronate is an intravenous bisphosphonate often used in children with osteogenesis imperfecta type 14 to help make bones less likely to break. It is usually given in cycles through a vein and may improve bone density and reduce bone pain over time.
Zoledronic acid is another intravenous bisphosphonate that may be used instead of pamidronate, sometimes with less frequent dosing. Doctors monitor calcium levels and kidney function, because flu-like symptoms or low calcium can happen after treatment.
Alendronate or risedronate are oral bisphosphonates that are used in some people, especially when intravenous treatment is not preferred. They can help bone density, but they may be less practical for some families because dosing instructions are strict and stomach irritation can occur.
Acetaminophen and ibuprofen are commonly used to treat pain from fractures, procedures, or the early symptoms of osteogenesis imperfecta type 14 flare-ups after overuse. These drugs do not strengthen bone, but they can make daily activities, sleep, and rehabilitation easier while healing is underway.
Genetic influences
For many living with osteogenesis imperfecta type 14, easy fractures and slower growth trace back to a gene change present from birth. This specific form of osteogenesis imperfecta is caused by changes in the TMEM38B gene, which helps bone-forming cells manage calcium in a way that supports normal bone strength. Osteogenesis imperfecta type 14 is usually inherited in an autosomal recessive pattern, which means a child receives a nonworking copy of TMEM38B from each parent. A carrier means you hold the gene change but may not show symptoms. Even in the same family, symptoms can vary, from fewer fractures to more frequent breaks, bone deformity, or spine problems, so the gene result does not predict every detail. In many families, genetic testing for osteogenesis imperfecta type 14 helps confirm the diagnosis and clarify the chance that future children could also be affected.
Is Osteogenesis imperfecta type 14 genetic?
Genetics are central to osteogenesis imperfecta type 14. It is caused by changes in the TMEM38B gene, usually inherited in an autosomal recessive pattern, meaning both copies are affected. Genetic testing can confirm the diagnosis and help with family planning.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are common in the wider population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Osteogenesis imperfecta type 14, treatment is shaped by the gene change causing the condition, because it affects how bone is formed and how easily fractures can happen. This means care is usually tailored around day-to-day needs such as preventing breaks, managing pain, supporting movement, and watching for spine or growth problems, rather than trying to correct the gene itself. Medicines that help slow bone breakdown, such as bisphosphonates, are sometimes used to strengthen bone and lower fracture risk, but the benefit can vary from one person to another.
Not every difference in response is genetic, but in Osteogenesis imperfecta type 14 the underlying genetic cause helps doctors judge how severe the condition may be and how closely treatment should be monitored. Right now, there is no standard pharmacogenetic test that can reliably tell doctors which bone medicine will work best for this type of osteogenesis imperfecta. Instead, choices about treatment are usually based on fracture history, bone density, pain, growth, mobility, and side effects over time. This is one reason why treatment for Osteogenesis imperfecta type 14 often needs regular review, especially when families are looking for the best options for fragile bones and repeated fractures.
Interactions with other conditions
People living with osteogenesis imperfecta type 14 often deal with fragile bones first, but other health issues can have a bigger effect when they increase the chance of falls, weaken muscles, or make breathing harder. For example, if someone also has asthma or frequent lung infections, chest wall changes and weaker breathing muscles can make cough, shortness of breath, and recovery from illness more difficult. Low muscle tone, joint looseness, or neurologic conditions that affect balance can also raise the risk of fractures because even minor slips or awkward movements may lead to injury. Doctors call it a comorbidity when two conditions occur together. Hearing problems, dental problems, and spinal curvature may add to day-to-day challenges in osteogenesis imperfecta type 14, especially as children grow and activity levels change. Because the early symptoms of osteogenesis imperfecta type 14 can overlap with other causes of frequent fractures or poor growth, careful follow-up helps clinicians spot related conditions and adjust care, medicines, physical therapy, and bone protection plans safely.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Osteogenesis imperfecta type 14?
Other forms of osteogenesis imperfecta, especially the more common types, can look very similar because they also cause bones that break easily, short height, and changes in bone shape. Doctors may also consider rickets, which is soft bones often linked to low vitamin D, or hypophosphatasia, a rare condition that keeps bones from hardening the way they should. In babies and young children, repeated broken bones can sometimes also raise concern for injury, including abuse, so careful exams and genetic testing are often used to tell these apart.
History
Long before modern testing, doctors and families were already noticing children whose bones seemed to break far too easily, sometimes after a small fall or even routine handling. Early medical reports grouped many of these cases together under what later became known as osteogenesis imperfecta, a condition linked to fragile bones. At first, descriptions were based only on what could be seen in daily life and on exam: repeated fractures, short stature, bowed limbs, and in some children, more serious bone changes from infancy onward.
As medical science improved, it became clear that osteogenesis imperfecta was not just one uniform disorder. Some people had milder symptoms and stayed active with relatively few fractures, while others had severe bone fragility starting before or shortly after birth. In recent decades, awareness has grown that these differences reflect several distinct subtypes. Osteogenesis imperfecta type 14 was recognized during this period, when researchers were able to sort patients more carefully by their clinical features and later identify an underlying genetic cause for this particular form.
That shift mattered because it helped explain why two children with brittle bones might not have exactly the same course or care needs. Many living with osteogenesis imperfecta type 14 have features that overlap with other forms, so earlier cases may not have been labeled this way at the time. As specialists learned more, the history of osteogenesis imperfecta type 14 became part of a broader move in medicine: from describing visible symptoms alone to understanding the biological pathways behind them.
Today, that history helps doctors make sense of the early symptoms of osteogenesis imperfecta type 14 and avoid older misunderstandings. It also gives families clearer answers than were possible in the past. While the name “type 14” is relatively new, the day-to-day challenges it describes, such as frequent fractures, growth problems, and the need for ongoing orthopedic care, have been recognized for much longer.